← All Sponsors
SPONSOR

LB Pharmaceuticals Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Bipolar I Disorder
NCT07494305 Phase 2
Recruiting

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Bipolar I Disorder
United States View Trial →